Ergocalciferol and Epzicom drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Epzicom (abacavir sulfate; lamivudine). Common drug interactions include fracture among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Epzicom. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.

What is Epzicom?

Epzicom has active ingredients of abacavir sulfate; lamivudine. It is often used in hiv infection. eHealthMe is studying from 4,937 Epzicom users. Check the latest studies of Epzicom.

On Jul, 15, 2026

43 people who take Ergocalciferol and Epzicom together, and have interactions are studied.

Ergocalciferol and Epzicom drug interactions.

What are the common drug interactions of Ergocalciferol and Epzicom, by gender? *:

female:

Fracture
Hip fracture
Hyperkalaemia (damage to or disease of the kidney)
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Lower limb fracture
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Mobility decreased (ability to move is reduced)
Proteinuria (presence of protein in the urine)
Renal injury (kidney injury)

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Osteoporosis (bones weak and more likely to break)
Bone density decreased
Dyspnoea (difficult or laboured respiration)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Renal disorder (kidney disease)
Arthralgia (joint pain)

What are the common drug interactions of Ergocalciferol and Epzicom, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Renal failure (kidney dysfunction)
Anxiety
Depression
Anogenital warts
Blood hiv rna increased
Kidney infection
Viral load increased
Humerus fracture (injury to the upper arm bone)
Multiple fractures
Tooth loss

40-49:

Intervertebral disc degeneration (spinal disc degeneration)
Lower limb fracture
Mobility decreased (ability to move is reduced)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteonecrosis (death of bone)
Renal impairment (severely reduced kidney function)
Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Pain
Chronic kidney disease
Decreased activity
Quality of life decreased
Osteoporosis (bones weak and more likely to break)
Depression
Fatigue (feeling of tiredness)

60+:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Dysstasia (difficulty in standing)
Gait disturbance
Haemolytic anaemia (anaemia due to haemolysis)
Immobile (not moving)
Impaired work ability
Osteoporosis (bones weak and more likely to break)
Pain in extremity

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 13.95%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 11.63%
High Blood Cholesterol: 5 people, 11.63%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 11.63%
Asthma: 5 people, 11.63%
Pain: 4 people, 9.30%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.30%
Bacterial Infection: 4 people, 9.30%
Hypersensitivity: 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Ergocalciferol and Epzicom?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously